GeneDx Holdings Corp vs State Street SPDR S&P Homebuilders ETF — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while State Street SPDR S&P Homebuilders ETF trades at $105.91. The key difference: State Street SPDR S&P Homebuilders ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| WGS | XHB | |
|---|---|---|
Market Cap | $1.80B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $167.51 | $121.36 |
52-Week Low | $34.51 | $94.86 |
Enterprise Value | $1.80B | — |
Trailing returns across standard periods
Latest headlines on both assets
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →